Literature DB >> 667844

Multicellular tumor spheroid formation by breast cancer cells isolated from different sites.

J M Yuhas, A E Tarleton, K B Molzen.   

Abstract

Fourteen breast cancer lines (8 human, 5 rat, and 1 mouse) have been studied in terms of their ability to form multicellular tumor spheroids (MTS) with the agar-base method. Only 8 of the lines formed MTS in contrast to a 100% efficiency in a series of 11 varied tumors reported in the initial studies with this method. We have compared the lines that do and do not form MTS in terms of a variety of characteristics (e.g., estrogen receptors, time in serial passage, growth in nude mice, etc.), and only one characteristic, the source of the original tumor cells, was predictive of MTS-forming ability. All 8 of the breast cancer lines (and the original 11 lines) that formed MTS had been obtained from solid growths (primaries or metastases), while the 6 breast cancer lines that did not form MTS were all derived from pleural effusions. Similarly, artificial selection for an ascites variant of the MTS-forming rat 13762 adenocarcinoma line produced the 13762-A line, which could no longer form MTS. These results suggest that breast cancer cells derived from pleural effusions are genetically different from the bulk of the tumor cells in solid breast cancer samples, that they are unable to grow in true solid form, and that these differences persist in spite of prolonged propagation in tissue culture.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 667844

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Comparative Study of Multicellular Tumor Spheroid Formation Methods and Implications for Drug Screening.

Authors:  Maria F Gencoglu; Lauren E Barney; Christopher L Hall; Elizabeth A Brooks; Alyssa D Schwartz; Daniel C Corbett; Kelly R Stevens; Shelly R Peyton
Journal:  ACS Biomater Sci Eng       Date:  2017-03-13

2.  Continuous three-dimensional cultures of MCF-7 cells in serum free medium.

Authors:  R Beaupain; G Prévost; C Mainguené; C Lainé-Bidron; A Tamboise; E Tamboise
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-12       Impact factor: 2.416

Review 3.  Multicellular spheroids. A review on cellular aggregates in cancer research.

Authors:  W Mueller-Klieser
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

4.  Dehydroepiandrosterone inhibits events related with the metastatic process in breast tumor cell lines.

Authors:  Rebeca López-Marure; Estrella Zapata-Gómez; Leticia Rocha-Zavaleta; María Cecilia Aguilar; Magali Espinosa Castilla; Jorge Meléndez Zajgla; Noemí Meraz-Cruz; Claudia Huesca-Gómez; Ricardo Gamboa-Ávila; Erika Olivia Gómez-González
Journal:  Cancer Biol Ther       Date:  2016-06-03       Impact factor: 4.742

5.  Growth, morphology and chemosensitivity studies on postconfluent cells cultured in 'V'-bottomed microtiter plates.

Authors:  P E Pizao; D M Lyaruu; G J Peters; J van Ark-Otte; B Winograd; G Giaccone; H M Pinedo
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

Review 6.  Advances in the development of improved animal-free models for use in breast cancer biomedical research.

Authors:  Sophie Roberts; Valerie Speirs
Journal:  Biophys Rev       Date:  2017-07-26

7.  Multicellular tumour spheroids: a model for combined in vivo/in vitro assay of tumour immunity.

Authors:  F Culo; J M Yuhas; A J Ladman
Journal:  Br J Cancer       Date:  1980-01       Impact factor: 7.640

8.  Treatment of tumours with the combination of WR-2721 and cis-dichlorodiammineplatinum (II) or cyclophosphamide.

Authors:  J M Yuhas; J M Spellman; S W Jordan; M C Pardini; S M Afzal; F Culo
Journal:  Br J Cancer       Date:  1980-10       Impact factor: 7.640

9.  In vitro cytotoxic drug sensitivity testing of human tumour xenografts grown as multicellular tumour spheroids.

Authors:  A C Jones; I J Stratford; P A Wilson; M J Peckham
Journal:  Br J Cancer       Date:  1982-12       Impact factor: 7.640

10.  Interactions of doxorubicin and cis-platin in squamous carcinoma cells in culture.

Authors:  N Kohno; T Ohnuma; M Kaneko; J F Holland
Journal:  Br J Cancer       Date:  1988-09       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.